Abstract
The Netherlands' Ministry of Health and the health insurance companies have drawn up a list of preparations which will no longer be reimbursed. The ocular antibiotic preparations Polyspectran and Terramycin are on the list. However, there are no satisfactory alternative with respect to the broadness of the antibiotic spectrum required. In addition, some alternatives have serious side effects or may induce bacterial resistance.
MeSH terms
-
Anti-Bacterial Agents / economics
-
Bacitracin / economics
-
Drug Therapy, Combination / administration & dosage
-
Drug Therapy, Combination / economics*
-
Gramicidin / economics
-
Humans
-
Insurance, Health, Reimbursement*
-
Neomycin / economics
-
Netherlands
-
Ophthalmic Solutions / economics*
-
Oxytetracycline / economics
-
Polymyxin B / economics
Substances
-
Anti-Bacterial Agents
-
Ophthalmic Solutions
-
Bacitracin
-
Gramicidin
-
Neomycin
-
Polymyxin B
-
Oxytetracycline